BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29367713)

  • 21. High dose chemotherapy and stem cell rescue for metastatic germ cell tumours: long-term results from a single institution.
    Kruse V; Noens L; Lumen N; Hoebeke P; Van Belle S; Rottey S
    Acta Clin Belg; 2011; 66(4):254-9. PubMed ID: 21938979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose chemotherapy for germ cell tumors: do we have a model?
    Necchi A; Lanza F; Rosti G; Martino M; Farè E; Pedrazzoli P;
    Expert Opin Biol Ther; 2015 Jan; 15(1):33-44. PubMed ID: 25243977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
    Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party.
    Rosti G; De Giorgi U; Wandt H; Lioure B; Leyvraz S; Kolbe K; Papiani G; Ballardini M; Kulekci A; Demirer T;
    Bone Marrow Transplant; 2004 Dec; 34(12):1033-7. PubMed ID: 15516940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
    Faure-Conter C; Orbach D; Cropet C; Baranzelli MC; Martelli H; Thebaud E; Vérité C; Rome A; Fasola S; Corradini N; Rocourt N; Frappaz D; Kalfa N; Patte C
    Pediatr Blood Cancer; 2014 Feb; 61(2):253-9. PubMed ID: 23940114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
    Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
    J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
    Vaena DA; Abonour R; Einhorn LH
    J Clin Oncol; 2003 Nov; 21(22):4100-4. PubMed ID: 14615439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
    Suleiman Y; Siddiqui BK; Brames MJ; Abonour R; Einhorn LH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):161-3. PubMed ID: 22892555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.
    Petrelli F; Coinu A; Rosti G; Pedrazzoli P; Barni S
    Med Oncol; 2017 Aug; 34(8):133. PubMed ID: 28653284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012.
    Necchi A; Lo Vullo S; Bregni M; Rosti G; Mariani L; Raggi D; Giannatempo P; Secondino S; Schumacher K; Massard C; Kanfer E; Oechsle K; Laszlo D; Michieli M; Ifrah N; Mercier M; Crysandt M; Wuchter P; Nagler A; Wahlin A; Martino M; Badoglio M; Pedrazzoli P; Lanza F;
    Clin Genitourin Cancer; 2017 Feb; 15(1):163-167. PubMed ID: 27444987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
    Lorch A; Kleinhans A; Kramar A; Kollmannsberger CK; Hartmann JT; Bokemeyer C; Rick O; Beyer J
    J Clin Oncol; 2012 Mar; 30(8):800-5. PubMed ID: 22291076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party.
    De Giorgi U; Blaise D; Lange A; Viens P; Marangolo M; Madroszyk A; Brune M; Afanassiev BV; Rosti G; Demirer T
    Bone Marrow Transplant; 2007 Dec; 40(11):1045-8. PubMed ID: 17922037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a risk stratification system to guide treatment for female germ cell tumors.
    Meisel JL; Woo KM; Sudarsan N; Eng J; Patil S; Jacobsen EP; Murali R; Gardner GJ; Bosl GJ; Aghajanian C; Feldman DR
    Gynecol Oncol; 2015 Sep; 138(3):566-72. PubMed ID: 26115974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
    Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
    Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
    Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
    Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
    González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
    Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
    Nichols CR; Breeden ES; Loehrer PJ; Williams SD; Einhorn LH
    J Natl Cancer Inst; 1993 Jan; 85(1):36-40. PubMed ID: 7677934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Dose Chemotherapy and Autologous Stem Cell Transplant.
    Adra N; Abonour R
    Urol Clin North Am; 2019 Aug; 46(3):439-448. PubMed ID: 31277738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
    Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
    Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.